Anti-EGFR antibody-drug conjugate carrying an inhibitor targeting CDK restricts triple-negative breast cancer growth.
Cheung A, Chenoweth AM, Johansson A, Laddach R, Guppy N, Trendell J, Esapa B, Mavousian A, Navarro-Llinas B, Haider S, Romero-Clavijo P, Hoffmann RM, Andriollo P, Rahman KM, Jackson P, Tsoka S, Irshad S, Roxanis I, Grigoriadis A, Thurston DE, Lord CJ, Tutt ANJ, Karagiannis SN.
Cheung A, et al. Among authors: rahman km.
Clin Cancer Res. 2024 May 21. doi: 10.1158/1078-0432.CCR-23-3110. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38772416